nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease
|
Kang, Soo-Sang |
|
2018 |
32 |
2 |
p. 233-240 |
artikel |
2 |
An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
|
Yoshihara, Fumiki |
|
2018 |
32 |
2 |
p. 183-190 |
artikel |
3 |
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
|
Bays, Harold E. |
|
2018 |
32 |
2 |
p. 175-180 |
artikel |
4 |
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies
|
Hoppe, Liesa K. |
|
2018 |
32 |
2 |
p. 197-212 |
artikel |
5 |
Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes
|
Birnbaum, Yochai |
|
2018 |
32 |
2 |
p. 135-145 |
artikel |
6 |
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry
|
Xanthopoulou, Ioanna |
|
2018 |
32 |
2 |
p. 191-196 |
artikel |
7 |
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
|
Bays, Harold E. |
|
2018 |
32 |
2 |
p. 181 |
artikel |
8 |
Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?
|
Flores, Eduardo |
|
2018 |
32 |
2 |
p. 213-222 |
artikel |
9 |
Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart
|
Bińkowski, Bartłomiej Jacek |
|
2018 |
32 |
2 |
p. 169-173 |
artikel |
10 |
Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
|
Rossello, Xavier |
|
2018 |
32 |
2 |
p. 127-133 |
artikel |
11 |
Old Drugs for New Indications in Cardiovascular Medicine
|
Arbel, Yaron |
|
2018 |
32 |
2 |
p. 223-232 |
artikel |
12 |
Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats
|
Kosuru, Ramoji |
|
2018 |
32 |
2 |
p. 147-163 |
artikel |
13 |
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
|
Do Carmo, Helison |
|
2018 |
32 |
2 |
p. 165-168 |
artikel |